Follow Us:
Individualized Therapies Incorporating Novel Agents for Non-Small-Cell Lung Cancer: 2013 ASCO Update
This webcast is jointly sponsored by A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.
 |
 |
This activity is supported by educational grants from: Genentech BioOncology and Lilly USA, LLC.
Specialty: Hematology/Oncology
Release date: October 24, 2013
Valid through: October 24, 2015
Target Audience:
Program Overview:
These webcasts are intended to improve care of patients with NSCLC by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of molecular profiling and personalized therapies at various stages of clinical development will be given significant focus. This enduring online activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
This program consists of 2 continuing education activites.